HUTCHMED to Receive Milestone Payment from Takeda following First European Reimbursement for FRUZAQLA® (fruquintinib)
HUTCHMED (China) Limited — US$10 million milestone payment to HUTCHMED follows first national reimbursement in Europe — — Follows…